Cargando…
Development of treatment options for Chinese patients with advanced squamous cell lung cancer: focus on afatinib
Lung cancer is the leading cause of cancer death in China, and approximately one third of these cancers are squamous cell carcinoma (SqCC) of the lung. Ethnic diversity and country-specific environmental factors can account for interindividual variations in response to and tolerability of anticancer...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390854/ https://www.ncbi.nlm.nih.gov/pubmed/30863118 http://dx.doi.org/10.2147/OTT.S188296 |